León JC

Language: Spanish
References: 25
Page: 48-51
PDF size: 123.91 Kb.

REFERENCES

1. Omerhoca S, Akkas SY, Icen NK. Multiple sclerosis: diagnosis and differential diagnosis. Noro Psikiyatr Ars. 2018; 55(Suppl 1): S1-S9.

2. Katz Sand I. Classification, diagnosis, and differential diagnosis of multiple sclerosis. Curr Opin Neurol. 2015; 28(3): 193-205.

3. Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler. 2008; 14(9): 1157-74.

4. Di Pauli F, Mader S, Rostasy K, Schanda K, Bajer-Kornek B, Ehling R, et al. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clin Immunol. 2011; 138: 247-254.

5. Bacigaluppi S, Polonara G, Zavanone ML, Campanella R, Branca V, Gaini SM, et al. Schilder's disease: non-invasive diagnosis?: a case report and review. Neurol Sci. 2009; 30: 421-430.

6. Hardy TA, Tobin WO, Lucchinetti CF. Exploring the overlap between multiple sclerosis, tumefactive demyelination and Baló's concentric sclerosis. Mult Scler. 2016; 22: 986-992. Mult Scler. 2016; 22: 986-992.

7. Kuhlmann T, Lassmann H, Brück W. Diagnosis of inflammatory demyelination in biopsy specimens: a practical approach. Act Neuropathol. 2008; 115: 275-287.

8. De Seze J, Kremer L, Collongues N. Neuromyelitis optica spectrum disorder (NMOSD): a new concept. Rev Neurol (Paris). 2016; 172: 256-262.

9. Akman-Demir G, Serdaroglu P, Tasçi B. Clinical patterns of neurological involvement in Behcet's disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain. 1999; 122 (Pt 11): 2171-2182.

10. Kocer N, Islak C, Siva A, Saip S, Akman C, Kantarci O, Hamuryudan V. CNS involvement in neuro-Behçet's syndrome: an MRI study. AJNR Am J Neuroradiol. 1999; 20: 1015-1024.

11. Tani C, Palagini L, Moraes-Fontes MF, Carli L, Mauri M, Bombardieri S, et al. Neuropsychiatric questionnaires in systemic lupus erythematosus. Clin Exp Rheumatol. 2014; 32: 59-64.

12. Cannerfelt B, White matter lesions and brain atrophy in systemic lupus erythematosus patients: correlation to cognitive dysfunction in a cohort of systemic lupus erythematosus patients using different definition models for neuropsychiatric systemic lupus erythematosus. Lupus. 2018; 27: 1140-1149.

13. Berkowitz AL, Samuels MA. The neurology of Sjogren's syndrome and the rheumatology of peripheral neuropathy and myelitis. Pract Neurol. 2014; 14: 14-22.

14. Moreira I, Teixeira F, Martins Silva A, Vasconcelos C, Farinha F, Santos E. Frequent involvement of central nervous system in primary Sjogren syndrome. Rheumatol Int. 2015; 35: 289-294.

15. Tüzün E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist. 2007; 13: 261-271.

16. McKeon A, Pittock SJ. Paraneoplastic encephalomyelopathies: pathology and mechanisms. Acta Neuropathol. 2011; 122: 381-400.

17. Hebel R, Dubaniewicz-Wybieralska M, Dubaniewicz A. Overview of neurosarcoidosis: recent advances. J Neurol. 2015; 262: 258-267.

18. Asakura K, Muto T. Neurological involvement in Wegener's granulomatosis. Brain Nerve. 2013; 65: 1311-1317.

19. Younger DS. Epidemiology of Lyme Neuroborreliosis. Neurol Clin. 2016; 34: 875-886.

20. Halperin JJ. Neuroborreliosis. J Neurol. 2017; 264: 1292-1297.

21. Bangham CR, Araujo A, Yamano Y, Taylor GP. HTLV-1-associated myelopathy/tropical spastic paraparesis. Nat Rev Dis Primers. 2015; 1: 15012.

22. Letendre S. Central nervous system complications in HIV disease: HIV associated neurocognitive disorder. Top Antivir Med. 2011; 19: 137-142.

23. Berger JR, Dean D. Neurosyphilis. Handb Clin Neurol. 2014; 121: 1461-1472.

24. Berger J, Forss-Petter S, Eichler FS. Pathophysiology of X-linked adrenoleukodystrophy. Biochimie. 2014; 98(100): 135-142.

25. Kumar N. Neurologic aspects of cobalamin (B12) deficiency. Handb Clin Neurol. 2014; 120: 915-926.